Reports overnight says that "flu drug candidate (peramivir) failed in trial".
http://www.businessweek.com/ap/financialnews/D98276PG0.htm
This development is good for BTA but not good for the seasonal and swine flu battle.
Lani here we come!
- Forums
- ASX - By Stock
- BTA
- peramivir failed in a clinical trial
peramivir failed in a clinical trial
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online